Page last updated: 2024-08-16

thalidomide and cytosine

thalidomide has been researched along with cytosine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kaul, DR; Nicolasora, NP; Reddy, P1
Baer, MR; Gojo, I1
Avril, MF; Dallot, A; Di Lucca-Christment, J; Dupin, N; Gressier, L; Jacobelli, S; Laude, H; Morini, JP; Plantier, F; Rosenberg, F; Rozenberg, F1

Other Studies

3 other study(ies) available for thalidomide and cytosine

ArticleYear
Biopsy-proven adenoviral diarrhea responding to low-dose cidofovir.
    Transplant infectious disease : an official journal of the Transplantation Society, 2008, Volume: 10, Issue:5

    Topics: Adenoviridae; Adenovirus Infections, Human; Aged; Antigens, Viral; Antiviral Agents; Biopsy; Cidofovir; Cytosine; Dexamethasone; Diarrhea; Drug Administration Schedule; Feces; Gastric Mucosa; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Inclusion Bodies, Viral; Intranuclear Inclusion Bodies; Male; Multiple Myeloma; Organophosphonates; Thalidomide; Treatment Outcome

2008
Novel agents for the treatment of acute myeloid leukemia in the older patient.
    Journal of the National Comprehensive Cancer Network : JNCCN, 2011, Volume: 9, Issue:3

    Topics: Adenine Nucleotides; Age Factors; Aged; Antineoplastic Agents; Arabinonucleosides; Azacitidine; Clofarabine; Cytosine; Decitabine; Disease-Free Survival; Hematopoietic Stem Cell Transplantation; Humans; Lenalidomide; Leukemia, Myeloid, Acute; Middle Aged; Prognosis; Quinolones; Thalidomide

2011
Anogenital pseudotumoral herpes and HIV infection: a new challenge for diagnosis and treatment.
    AIDS (London, England), 2012, Feb-20, Volume: 26, Issue:4

    Topics: Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Carcinoma, Squamous Cell; Cidofovir; Condylomata Acuminata; Cytosine; Diagnosis, Differential; Female; Foscarnet; Humans; Male; Middle Aged; Organophosphonates; Papillomavirus Infections; Thalidomide; Treatment Outcome; Tumor Virus Infections

2012